Dr Reddy's gets FDA nod for 'Tosymra' migraine nasal spray

The drug maker said the audit of its API manufacturing plant at Miryalaguda in Telangana, by the US FDA, has been completed.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2Hyg0YX
via IFTTT